LDLR and atherosclerosis: It has been used for the in vivo overexpression of low-density lipoprotein and very low-density lipoprotein receptors, resulting in moderate reductions in plasma cholesterol and atherosclerosis in a murine model of familial hypercholesterolemia [111].